论文部分内容阅读
目的：观察双羟二丁基乙醚对治疗非结石性慢性胆囊炎（ＣＡＣ）的疗效。方法：ＣＡＣ病人１２２例，随机分为去氢胆酸治疗６４例作对照组（男性３０例，女性３４例，年龄３８±ｓ４ａ），双羟二丁基乙醚治疗５８例作治疗组（男性２７例，女性３１例，年龄３９±４ａ），治疗组应用双羟二丁基乙醚５００ｍｇ，ｐｏ，ｔｉｄ×３０ｄ；对照组用去氢胆酸５００ｍｇ，ｐｏ，ｔｉｄ×３０ｄ。结果：治疗组总有效率为８６％，对照组为７０％（Ｐ＜０．０５）。２组治疗后，体征与症状消失时间治疗组快于对照组（Ｐ均＜０．０１）。结论：双羟二丁基乙醚治疗ＣＡＣ疗效显著，可首选用来治疗ＣＡＣ。
Objective: To observe the effect of bishydroxyethyl ether on the treatment of non-calcified chronic cholecystitis (CAC). Methods: One hundred and twenty-two patients with CAC were randomly divided into dehydrocholic acid treatment group (64 cases), control group (30 males and 34 females, age 38 ± s4a), and 58 cases treated with BHT Cases, 31 females, age 39 ± 4a), the treatment group with dihydroxy dibutyl ether 500mg, po, tid × 30d; control group with hydrochloric acid 500mg, po, tid × 30d. Results: The total effective rate was 86% in the treatment group and 70% in the control group (P <0.05). After treatment, the disappearance of signs and symptoms in the treatment group was faster than that in the control group (all P <0.01). CONCLUSION: Bicldibenzyl ether is effective in treating CAC and may be the first choice for CAC.